Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Fortis · SciRah

Researcher profile · Semantic Scholar

S. Fortis

Share profile

S. Fortis — researcher profile on SciRah

h-index: 13
Works: 47
Citations: 816

Most-cited papers

The balance between breast cancer and the immune system: challenges for prognosis and clinical benefit from immunotherapies.
C. Baxevanis, S. Fortis, S. Perez
2019Seminars in Cancer Biology142 citations
Semantic Scholar
The prognostic significance of peritumoral tertiary lymphoid structures in breast cancer
Sofopoulos Michail, S. Fortis, Christoforos K Vaxevanis, Nectaria N. Sotiriadou +5 more
2019Cancer Immunology and Immunotherapy134 citations Open access
Semantic Scholar
Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer
S. Fortis, Sofopoulos Michail, Nectaria N. Sotiriadou, Christoforos Haritos +8 more
2017Journal of Immunotherapy for Cancer80 citations Open access
Semantic Scholar
Treatment with native heterodimeric IL-15 increases cytotoxic lymphocytes and reduces SHIV RNA in lymph nodes
Dionysios C. Watson, Eirini Moysi, A. Valentin, C. Bergamaschi +13 more
2018PLoS Pathogens68 citations Open access
Semantic Scholar
IGF2BP1 Expression in Human Mesenchymal Stem Cells Significantly Affects Their Proliferation and Is Under the Epigenetic Control of TET1/2 Demethylases
L. Mahaira, Olga Katsara, Efthimia Pappou, Eleni G. Iliopoulou +6 more
2014Stem Cells and Development50 citations
Semantic Scholar
The role of immune infiltrates as prognostic biomarkers in patients with breast cancer
C. Baxevanis, Sofopoulos Michail, S. Fortis, S. Perez
2019Cancer Immunology and Immunotherapy46 citations
Semantic Scholar
DNA Damage Response Mechanisms in Head and Neck Cancer: Significant Implications for Therapy and Survival
Chara Papalouka, M. Adamaki, Panagiota Batsaki, P. Zoumpourlis +5 more
2023International Journal of Molecular Sciences32 citations Open access
Semantic Scholar
Promising Biomarkers in Head and Neck Cancer: The Most Clinically Important miRNAs
Arsinoe C. Thomaidou, Panagiota Batsaki, M. Adamaki, M. Goulielmaki +3 more
2022International Journal of Molecular Sciences31 citations Open access
Semantic Scholar
In Situ Characterization of Follicular Helper CD4 T Cells Using Multiplexed Imaging
Kalliopi Ioannidou, Daba-Rokhya Ndiaye, A. Noto, C. Fenwick +4 more
2021Frontiers in Immunology25 citations Open access
Semantic Scholar
Circulating Plasma Cell-free DNA (cfDNA) as a Predictive Biomarker for Radiotherapy: Results from a Prospective Trial in Head and Neck Cancer.
M. Koukourakis, Erasmia T. Xanthopoulou, Ioannis M. Koukourakis, S. Fortis +3 more
2023Cancer Diagnosis & Prognosis22 citations Open access
Semantic Scholar
Prostate cancer: any room left for immunotherapies?
C. Baxevanis, S. Fortis, S. Perez
2019Immunotherapy17 citations Open access
Semantic Scholar
Immune profiling of melanoma tumors reflecting aggressiveness in a preclinical model
S. Fortis, L. Mahaira, E. Anastasopoulou, I. F. Voutsas +2 more
2017Cancer Immunology and Immunotherapy16 citations Open access
Semantic Scholar
Exploring Essential Issues for Improving Therapeutic Cancer Vaccine Trial Design
C. Baxevanis, S. Fortis, A. Ardavanis, S. Perez
2020Cancers14 citations Open access
Semantic Scholar
Serum miRNA-based distinct clusters define three groups of breast cancer patients with different clinicopathological and immune characteristics
S. Fortis, Christoforos K Vaxevanis, L. Mahaira, Sofopoulos Michail +7 more
2018Cancer Immunology and Immunotherapy12 citations
Semantic Scholar
HLA Class I Allele Expression and Clinical Outcome in De Novo Metastatic Prostate Cancer
S. Stokidis, S. Fortis, P. Kogionou, T. Anagnostou +2 more
2020Cancers11 citations Open access
Semantic Scholar
Potential Prognostic Molecular Signatures in a Preclinical Model of Melanoma.
S. Fortis, E. Anastasopoulou, I. F. Voutsas, C. Baxevanis +2 more
2017Anticancer Research11 citations Open access
Semantic Scholar
T-Cell Repertoire in Tumor Radiation: The Emerging Frontier as a Radiotherapy Biomarker
C. Baxevanis, A. Gritzapis, I. F. Voutsas, Panagiota Batsaki +4 more
2022Cancers10 citations Open access
Semantic Scholar
The thin red line between the immune system and cancer evolution
C. Baxevanis, M. Goulielmaki, M. Adamaki, S. Fortis
2022Translational Oncology10 citations Open access
Semantic Scholar
Next-Generation Sequencing Analysis of Mutations in Circulating Tumor DNA from the Plasma of Patients with Head–Neck Cancer Undergoing Chemo-Radiotherapy Using a Pan-Cancer Cell-Free Assay
M. Koukourakis, Erasmia T. Xanthopoulou, Ioannis M. Koukourakis, S. Fortis +4 more
2023Current Oncology8 citations Open access
Semantic Scholar
Frequencies of an Immunogenic HER-2/neu Epitope of CD8+ T Lymphocytes Predict Favorable Clinical Outcomes in Prostate Cancer
M. Goulielmaki, S. Stokidis, T. Anagnostou, I. F. Voutsas +3 more
2023International Journal of Molecular Sciences8 citations Open access
Semantic Scholar
Association between Intratumoral CD8+ T Cells with FoxP3+ and CD163+ Cells: A Potential Immune Intrinsic Negative Feedback Mechanism for Acquired Immune Resistance
S. Fortis, Sofopoulos Michail, M. Goulielmaki, N. Arnogiannaki +4 more
2022Cancers8 citations Open access
Semantic Scholar
Radiotherapy-Related Gene Signature in Prostate Cancer
S. Fortis, M. Goulielmaki, Nicolas Aubert, Panagiota Batsaki +6 more
2022Cancers8 citations Open access
Semantic Scholar
Peripheral T cell responses to tumour antigens are associated with molecular, immunogenetic and cellular features of breast cancer patients
Nicole Janssen, S. Fortis, Lisa Speigl, Christoforos Haritos +9 more
2016Breast Cancer Research and Treatment7 citations
Semantic Scholar
Pre-Existing Immunity Predicts Response to First-Line Immunotherapy in Non-Small Cell Lung Cancer Patients
A. Xagara, M. Goulielmaki, S. Fortis, Alexandros Kokkalis +10 more
2024Cancers6 citations Open access
Semantic Scholar
Correction: Treatment with native heterodimeric IL-15 increases cytotoxic lymphocytes and reduces SHIV RNA in lymph nodes
Dionysios C. Watson, Eirini Moysi, A. Valentin, C. Bergamaschi +13 more
2018PLoS Pathogens6 citations Open access
Semantic Scholar
The Prognostic Significance of Selected HLA Alleles on Prostate Cancer Outcome
S. Stokidis, C. Baxevanis, S. Fortis
2023International Journal of Molecular Sciences5 citations Open access
Semantic Scholar
The impact of radiation therapy on the TCR Vβ chain repertoire in patients with prostate cancer
M. Goulielmaki, N. Davanos, P. Kogionou, Panagiota Batsaki +9 more
2022International Journal of Oncology5 citations Open access
Semantic Scholar
Advancing the Biochemical Understanding of Maple Syrup Urine Disease and the Impact of Liver Transplantation: A Pilot Study.
S. Fortis, Abby L. Grier, J. Reisz, Monika Dzieciatkowska +4 more
2025Journal of Proteome Research3 citations
Semantic Scholar
Peripheral pre-existing cancer-antigen specific T-cell immunity as predictive biomarker for immunotherapy in NSCLC patients.
A. Xagara, S. Fortis, M. Goulielmaki, F. Koinis +7 more
2023Journal of Clinical Oncology3 citations Open access
Semantic Scholar
Identification of the novel HLA‐DRB1*11:308 allele in a Greek individual
M. Zamanakou, S. Vatsiou, Panagiota Batsaki, S. Fortis +1 more
2022HLA3 citations
Semantic Scholar
Erratum to: Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer
S. Fortis, Sofopoulos Michail, Nectaria N. Sotiriadou, Christoforos Haritos +8 more
2017Journal of Immunotherapy for Cancer3 citations Open access
Semantic Scholar
DRB1*11 allele expression and HER2 pre-existing immunity may predict benefit in breast cancer patients vaccinated with the HER2 modified AE37 peptide vaccine
E. Anastasopoulou, P. Tzonis, S. Fortis, L. Mahaira +7 more
2015Journal of Immunotherapy for Cancer3 citations Open access
Semantic Scholar
Correction: Kogionou et al. Radiotherapy-Related Gene Signature in Prostate Cancer. Cancers 2022, 14, 5032
P. Kogionou, S. Fortis, M. Goulielmaki, Nicolas Aubert +7 more
2023Cancers2 citations Open access
Semantic Scholar
Peripheral Blood CD8+ T-Lymphocyte Subsets Are Associated with Prognosis in Prostate Cancer Patients
C. Baxevanis, S. Stokidis, M. Goulielmaki, A. Gritzapis +1 more
2023Onco2 citations Open access
Semantic Scholar
A Blood-Based Immune Gene Signature with Prognostic Significance in Localized Prostate Cancer
S. Fortis, Panagiota Batsaki, S. Stokidis, Dimitra Moschandreou +4 more
2023Cancers2 citations Open access
Semantic Scholar
Identification of two novel alleles, HLA‐A*02:01:193 and ‐DQA1*02:17, in Greek individuals
Maria Zamanakou, Sophia Vatsiou, Savvas Stokidis, S. Fortis +1 more
2021HLA2 citations
Semantic Scholar
Identification of a Novel Immune-Gene Signature with Prognostic Value in Patients with Head and Neck Cancer: A Pilot Study
Panagiota Batsaki, S. Fortis, A. Gritzapis, Andriana Razou +7 more
2025Biochemical Genetics1 citations
Semantic Scholar
Novel biomarkers for prognosis in patients with localized prostate cancer.
M. Goulielmaki, S. Stokidis, T. Anagnostou, A. Gritzapis +3 more
2025Oncology Letters1 citations Open access
Semantic Scholar
Comparative study of pluripotency-related gene expression in Umbilical Cord Mesenchymal Stem Cells (UC-MSC) from IUGR, SGA and normally grown fetuses
P. Fotinopoulos, S. Fortis, Louiza Mahaira, Maria Salagianni +5 more
2024Hellenic Journal of Obstetrics and Gynecology1 citations Open access
Semantic Scholar
Combination Immunotherapy in Prostate Cancer
C. Baxevanis, M. Goulielmaki, A. Gritzapis, S. Fortis
2022Cancers1 citations Open access
Semantic Scholar
4th Symposium on Advances in Cancer Immunology and Immunotherapy, November 29–December 1, 2018, Athens, Greece
S. Fortis, A. Kotsakis, C. le Tourneau, O. Tsitsilonis +2 more
2019Cancer Immunology and Immunotherapy1 citations
Semantic Scholar
Activation of the human natural killer cells NK-92 with a lymphocyte-derived cytokine-rich supernatant.
I. F. Voutsas, P. Samara, M. Tsiatas, Margarita Skopeliti +4 more
20141 citations
Semantic Scholar
Immunoediting and precision biomarkers in prostate cancer: The emerging role of liquid biopsy, immune contexture and HLA genotype (Review)
C. N. Baxevanis, S. Stokidis, S. Fortis, M. Goulielmaki +2 more
2026International Journal of Oncology0 citations Open access
Semantic Scholar
Peripheral T-Cell Receptor β Repertoire Dynamics Correlate with Response to Anti-PD-L1 Therapy in Non-Small Cell Lung Cancer
M. Goulielmaki, S. Fortis, A. Xagara, Panagiota Batsaki +17 more
2026Cancers0 citations Open access
Semantic Scholar
21P Peripheral pre-existing T cell immunity as predictive biomarker in cancer immunotherapy for NSCLC patients
A. Xagara, S. Fortis, M. Goulielmaki, F. Koinis +6 more
2022Immuno-Oncology and Technology0 citations Open access
Semantic Scholar
Immune profiling of breast cancer patients: relationship between tumour antigen T cell responses with suppressor and effector leukocyte populations
Nicole Janssen, G. Pawelec, Lisa Speigl, S. Fortis +5 more
2015Journal of Immunotherapy for Cancer0 citations Open access
Semantic Scholar
Linking tumor with systemic environment in the search for novel biomarkers in breast cancer
S. Fortis, L. Mahaira, Sofopoulos Michail, Nectaria N. Sotiriadou +8 more
2015Journal of Immunotherapy for Cancer0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Baxevanis×34
Invite
C. Baxevanis — researcher profile on SciRah
M. Goulielmaki×19
Invite
M. Goulielmaki — researcher profile on SciRah
S. Perez×17
Invite
S. Perez — researcher profile on SciRah
A. Gritzapis×13
Invite
A. Gritzapis — researcher profile on SciRah

Panagiota Batsaki

×10

Invite

Panagiota Batsaki — researcher profile on SciRah

S. Stokidis×10

Invite

S. Stokidis — researcher profile on SciRah

Sofopoulos Michail×8

Invite

Sofopoulos Michail — researcher profile on SciRah

N. Arnogiannaki×7

Invite

N. Arnogiannaki — researcher profile on SciRah

Nectaria N. Sotiriadou×6

Invite

Nectaria N. Sotiriadou — researcher profile on SciRah

A. Ardavanis×6

Invite

A. Ardavanis — researcher profile on SciRah

Invite

L. Mahaira — researcher profile on SciRah

Christoforos K Vaxevanis×5

Invite

Christoforos K Vaxevanis — researcher profile on SciRah